Stock 301367 BMC MEDICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings BMC Medical Co., Ltd.

Equities

301367

CNE100005WQ4

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 24/05/2024 am IST 		5-day change 1st Jan Change
85.4 CNY -1.51% Intraday chart for BMC Medical Co., Ltd. -0.86% -29.86%
10/05 BMC Medical Co., Ltd. Approves Cash Dividend for the Year 2023 CI
24/04 BMC Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Analyst opinion has improved significantly over the past four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
BMC MEDICAL CO., LTD. Stock BMC Medical Co., Ltd.
-29.86% 766M -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+10.03% 223B
B
DANAHER CORPORATION Stock Danaher Corporation
+13.59% 194B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+20.01% 141B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.83% 109B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.05% 64.85B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+15.38% 52.7B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+3.96% 51.77B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+8.37% 44.12B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+3.27% 36.21B -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 301367 Stock
  4. Ratings BMC Medical Co., Ltd.